WR1065 conjugated to thiol-PEG polymers as novel anticancer prodrugs: broad spectrum efficacy, synergism, and drug resistance reversal
The lack of anticancer agents that overcome innate/acquired drug resistance is the single biggest barrier to achieving a durable complete response to cancer therapy. To address this issue, a new drug family was developed for intracellular delivery of the bioactive aminothiol WR1065 by conjugating it...
Main Authors: | Dale M. Walker, Tsvetelina I. Lazarova, Steven W. Riesinger, Miriam C. Poirier, Terri Messier, Brian Cunniff, Vernon E. Walker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1212604/full |
Similar Items
-
Drug synergism and dose-effect data analysis /
by: 226834 Tallarida, Ronald J.
Published: (2000) -
New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
by: Diana Duarte, et al.
Published: (2020-12-01) -
Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches
by: Nuno Vale, et al.
Published: (2022-12-01) -
Blockade of AMPK-Mediated cAMP–PKA–CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma
by: Hongying Zhang, et al.
Published: (2021-04-01) -
Strong Synergic Growth Inhibition and Death Induction of Cancer Cells by <i>Astragalus membranaceus</i> and <i>Vaccaria hispanica</i> Extract
by: Zoya Cohen, et al.
Published: (2022-11-01)